Study ID: TAL-TQT-101 | R09-0539
Study Title
- A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm
Teva Identifier
- TAL-TQT-101 | R09-0539
ClinicalTrials.gov Identifier
- NCT00964730
Study Status
- Completed
Trial Condition(s)
- Healthy
Interventions
- Drug: Talampanel | Drug: Moxifloxacin | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 50 Years
Trial Duration
- 10/01/2009 - 02/01/2010
Phase
- Phase 1
Study Type
Interventional
